Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × Celecoxib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Colonic Neoplasms 15 Rectal Neoplasms 12 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Neoplasm Metastasis 3 Liver Neoplasms 3 Carcinoma, Hepatocellular 3 Thymoma 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Adenocarcinoma Of Esophagus 2 Turcot syndrome 1 Thrombocytosis 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polyps 1 Pancreatic Cancer Metastatic 1 Pain, Postoperative 1 Neoplastic Syndromes, Hereditary 1 Neoplasms 1 Myeloproliferative Disorders 1

Interventions

pembrolizumab 5 Nivolumab 5 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 danvatirsen 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1 Interleukin-2 1 Immunoglobulin G 1 IMM-101 1 Fluorouracil 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡